China's Huagai Capital leads $146m round in HaiHe Biopharma

China's Huagai Capital leads $146m round in HaiHe Biopharma

Medical drugs in a pharmacy. Credit: Flickr/epSos .de

Quynh Nguyen

12 February, 2019

HaiHe BiopharmaHuagai Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.